Detalhe da pesquisa
1.
Trial of Cinpanemab in Early Parkinson's Disease.
N Engl J Med
; 387(5): 408-420, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921450
2.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
N Engl J Med
; 387(5): 421-432, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921451
3.
Publisher Correction: ß-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration.
Nature
; 567(7749): E15, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867589
4.
ß-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration.
Nature
; 566(7745): 503-508, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787438
5.
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice.
Mov Disord
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38576081
6.
Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.
Mov Disord
; 39(3): 462-471, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243775
7.
CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.
Brain
; 146(1): 209-224, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881523
8.
Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study.
Brain
; 146(8): 3258-3272, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881989
9.
Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study.
Alzheimers Dement
; 20(1): 91-102, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461299
10.
Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up.
Neurobiol Dis
; 177: 105997, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634823
11.
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis.
Mov Disord
; 38(9): 1585-1597, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449706
12.
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease.
Mov Disord
; 38(1): 68-81, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36267007
13.
Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
Mov Disord
; 38(4): 567-578, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781413
14.
Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease".
Mov Disord
; 38(7): 1127-1142, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156737
15.
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
Brain
; 145(2): 584-595, 2022 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894214
16.
Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset.
Brain
; 145(2): 644-654, 2022 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590685
17.
Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
Brain
; 145(2): 700-712, 2022 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288744
18.
The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease.
Mol Cell Neurosci
; 121: 103746, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660088
19.
C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study.
Alzheimers Dement
; 19(11): 4828-4840, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023079
20.
Detection and quantification of Aß-3-40 (APP669-711) in cerebrospinal fluid.
J Neurochem
; 160(5): 578-589, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34984682